Wednesday, April 29, 2009 1:00:05 PM
http://translate.google.ca/translate?hl=en&sl=zh-TW&u=http://news.epochtimes.com.tw/9/4/28/111076.h
tm&ei=Q3z4SZu0MJKgtgPC2-3cDg&sa=X&oi=translate&resnum=8&ct=result&prev=/search?q=cyberknife&hl=en&sa=N&as_qdr=d&start=80
*** translated from Chinese ***
Epoch Times, Taiwan
2009/04/28
The stereotactic radiosurgery equipment Cyberknife perform a surgery without anesthesia and cutting, and no hospitalization is needed. During the treatment patient listens to music. The treatment is about 10-minute and up to five days, can be effective to eradicate or control tumor cells. Patient is back to the course of normal daily life right after each treatment
67-year-old Mr. Chung has been customary to donate blood. After liver reaction with B, the examination revealed liver tumors. The tumors is located close to blood vessels and was inoperable. It was treated with alcohol embolization. After the treatment the tumor became larger with a diameter of 9cm. Various chemotherapy drugs have been tried still unable to control the disease. Doctors had no choice but to abandon the treatment, and declare him only 3-6 months of life.
After received the cyberknife treatment in Chi Mei Hospital, Mr. Zhong's tumor have been reduced by 70%, fetal protein values dropped to 57.8 from 30,180. Mr. Zhong has now return to normal life. Mrs. Zhong said that her husband had been preparing for the end. The Cyberknife changed her family from black-and-white into full-color. She hoped that the Cyberknife can benefit more patients in the future.
Dr Li-Ching Lin , director of radiation oncology in Chi Mei Hospital, pointed out that the current treatment of liver tumors with surgical resection, alcohol embolization, chemotherapy and radiation therapy-based, all have their limitations. Some patients' respond to embolization and chemotherapy are not satisfactory. A wide range of radiation around the tumor may also harm normal blood vessels and tissues.
Dr Zhang Jin-hongComputer, director of the Cyberknife Center, said that the 4th generation cyberknife which is just introduced from US is the only linear accelerator equipment in Mid-South Taiwan. The error margin is less than 1mm. The machine can produce a total of 1680 rays. Each course of treatment can be given the perspective of radiation oncology and can automatically lock the tumor radiation, and not hurt nerves or other cells.
"I call investing the greatest business in the world because you never have to swing... All day you wait for the pitch you like,... The problem when you're a money manager is that your fans keep yelling, 'Swing. you bum!'"
W. Buffett
Recent ARAY News
- Accuray Reports Fiscal 2024 Third Quarter Financial Results • PR Newswire (US) • 05/01/2024 08:06:00 PM
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024 • PR Newswire (US) • 04/25/2024 11:35:00 AM
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland • PR Newswire (US) • 04/18/2024 11:35:00 AM
- Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024 • PR Newswire (US) • 04/17/2024 08:05:00 PM
- New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System • PR Newswire (US) • 03/26/2024 11:35:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:15:22 PM
- Accuray Incorporated to Speak at 36th Annual Roth Conference • PR Newswire (US) • 03/04/2024 09:30:00 PM
- Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference • PR Newswire (US) • 02/27/2024 10:30:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 04:19:22 PM
- Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System • PR Newswire (US) • 02/13/2024 12:35:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 08:01:38 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/07/2024 09:15:46 PM
- Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • PR Newswire (US) • 02/05/2024 10:30:00 PM
- Accuray Reports Fiscal 2024 Second Quarter Financial Results • PR Newswire (US) • 01/31/2024 09:06:00 PM
- Providence Swedish Radiosurgery Center in Seattle Invests in Second Accuray CyberKnife® System, a Robotic Delivery Device That Makes Extremely Precise Radiation Treatments Possible in 1-5 Sessions • PR Newswire (US) • 01/25/2024 12:35:00 PM
- Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024 • PR Newswire (US) • 01/16/2024 10:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:15:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:15:14 PM
- Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® System • PR Newswire (US) • 12/05/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:51:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:50 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:44 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:41 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2023 01:50:37 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM